Cargando…
Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation
We systematically developed a prognostic model for pancreatic cancer that was compatible across different transcriptomic platforms and patient cohorts. After performing quality control measures, we used seven microarray datasets and two RNA sequencing datasets to identify consistently dysregulated g...
Autores principales: | Yan, Jie, Wu, Liangcai, Jia, Congwei, Yu, Shuangni, Lu, Zhaohui, Sun, Yueping, Chen, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066910/ https://www.ncbi.nlm.nih.gov/pubmed/32081836 http://dx.doi.org/10.18632/aging.102844 |
Ejemplares similares
-
Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma
por: Zhang, Li, et al.
Publicado: (2018) -
MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2
por: Sun, Yang, et al.
Publicado: (2015) -
Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2
por: Sun, Yang, et al.
Publicado: (2015) -
A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms
por: Chen, Xianlong, et al.
Publicado: (2022) -
Ezrin promotes invasion and metastasis of pancreatic cancer cells
por: Meng, Yunxiao, et al.
Publicado: (2010)